Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Active not recruiting 1

Sponsor Class

OTHER 38INDUSTRY 22UNKNOWN 2OTHER_GOV 1NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Rectal Neoplasms 18Colorectal Neoplasms 16Breast Neoplasms 10Pancreatic Neoplasms 6Colonic Neoplasms 6Stomach Neoplasms 5Neoplasm Metastasis 4Gallbladder Neoplasms 3Bile Duct Neoplasms 3Uterine Cervical Neoplasms 2Somatostatinoma 2Esophageal Neoplasms 2Anus Neoplasms 2Anal Canal Carcinoma 2Adenoma, Islet Cell 2Triple Negative Breast Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Ovarian Neoplasms 1Neuroectodermal Tumors, Primitive 1Neoplasms 1Lung Neoplasms 1Liver Neoplasms 1Kidney Neoplasms 1Insulinoma 1Inflammatory Breast Neoplasms 1Glucagonoma 1Gastro Oesophageal Cancer 1Gastrinoma 1Erythema Multiforme 1Central Nervous System Neoplasms 1

Interventions

Cyclophosphamide 2palbociclib 1olaparib 1fludarabine 1durvalumab 1binimetinib 1atezolizumab 1Methotrexate 1Cisplatin 1Carboplatin 1Capecitabine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Triple Negative Breast Neoplasms × Capecitabine × Clear all
NCT02445391 2026-06-01

Platinum in Treating Patients With Residual Triple-Negative Breast Cancer Following Neoadjuvant Chemotherapy

Eastern Cooperative Oncology Group

Phase 3 Active not recruiting
415 enrolled 15 charts
Breast

Breast Neoplasms, Triple Negative Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡